Europe approves

new blood thinner

from Pfizer, BMS

Associated Press, 05.20.11, 11:27 AM EDT

NEW YORK — Drugmaker Pfizer says European regulators have approved its highly-anticipated blood thinner Eliquis to prevent blood clots in patients who have had hip or knee replacement surgery.

The approval by the European commission means the drug, known as apixaban, will be available in the 27 countries of the European Union.

The drug was approved based on two studies that showed better outcomes for patients taking Eliquis rather than receiving an injection of the typical current treatment.

The drug has been promoted as a potential blockbuster drug for its ability to prevent blood clots with no bleeding side effects of older drugs like warfarin. However, last year the companies halted a 10,000-patient study due to excessive bleeding

Sourced & published by Henry Sapiecha

Tags: , , , , , , ,

Leave a Reply